Covered recipient · General Payments record
LISA A SARDANOPOLI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,711.89
- Reported across 85 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.32 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $147.80 | 6 |
| GlaxoSmithKline, LLC. | $73.33 | 3 |
| ABBVIE INC. | $50.67 | 2 |
| Exact Sciences Corporation | $22.58 | 1 |
| PFIZER INC. | $22.54 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.94 | 1 |
| Novo Nordisk AS | $19.12 | 1 |
| SANOFI PASTEUR INC. | $18.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.43 | 02/05/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106020149 | CMS |
| ABBVIE INC. | $29.24 | 05/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106020151 | CMS |
| Exact Sciences Corporation | $22.58 | 02/20/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1114874633 | CMS |
| GlaxoSmithKline, LLC. | $25.68 | 01/03/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1115952224 | CMS |
| GlaxoSmithKline, LLC. | $24.01 | 01/10/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116693769 | CMS |
| GlaxoSmithKline, LLC. | $23.64 | 04/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116097125 | CMS |
| Lilly USA, LLC | $24.51 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135091609 | CMS |
| Lilly USA, LLC | $21.96 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135143903 | CMS |
| Lilly USA, LLC | $26.38 | 02/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135134228 | CMS |
| Lilly USA, LLC | $22.22 | 04/17/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135143905 | CMS |
| Lilly USA, LLC | $27.16 | 05/23/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135156423 | CMS |
| Lilly USA, LLC | $25.57 | 06/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135157055 | CMS |
| Novo Nordisk Inc | $19.12 | 05/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1096632359 | CMS |
| PFIZER INC. | $22.54 | 05/01/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1132007164 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.94 | 01/11/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1153496966 | CMS |
| SANOFI PASTEUR INC. | $18.34 | 02/27/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1128735852 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.